Virology Journal 2012-01-01

Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model.

Jie Dai, En-Qiang Chen, Lang Bai, Dao-Yin Gong, Qiao-Ling Zhou, Xing Cheng, Fei-Jun Huang, Hong Tang

Index: Virol. J. 9 , 280, (2012)

Full Text: HTML

Abstract

The effects of Hepatitis B virus (HBV) rtA181T/sW172* mutation on viral replication and pathogenicity was concerned recently. This study aimed to investigate the biological characteristics of rtA181T/sW172* mutant strain of HBV in animal model.The rtA181T/sW172* mutant plasmid was constructed using the pHBV4.1 (wild type HBV) as a template. The wild and mutant HBV replication mouse models were established utilizing a hydrodynamic technique. The titers of hepatitis B surface antigen (HBsAg), hepatitis B e antigen, and HBV DNA in serum, and the levels of HBsAg, hepatitis B core antigen(HBcAg), HBV DNA replication intermediates (HBV DNA RI) and HBV RNA in liver were measured after 1, 3, 5, 7, 10, 12 and 15 days of plasmid injection.In wild-type HBV replication mouse model, serum HBsAg was high on day 1, 3, and 5, but became lower since day 7; while in mutant HBV mouse model, serum HBsAg was always at very low level. In liver tissues, HBV DNA RI of wild type HBV was detected on day 1 after transfection. The level subsequently peaked on day 3, gradually declined after day 5, and was almost undetectable on day 10. However, the HBV DNA RI levels of the mutant strain were always higher and lasted longer until day 15. Consistently, the expression levels of HBsAg and HBcAg in liver of the mutant group were significantly increased.In the case of the HBV rtA181T/sW172* mutation, the secretion of serum HBsAg was impaired, whereas HBV DNA replication and HBsAg/HBcAg expression were increased in liver. These results suggest that the mutation can impair HBsAg secretion, and may cause the accumulation of viral core particles in liver.


Related Compounds

  • Adefovir
  • Telbivudine

Related Articles:

In vitro evaluation of 9-(2-phosphonylmethoxyethyl)adenine ester analogues, a series of anti-HBV structures with improved plasma stability and liver release.

2014-11-01

[Arch. Pharm. Res. 37(11) , 1416-25, (2014)]

Quantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor.

2015-01-01

[Sci. Rep. 5 , 10405, (2015)]

Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.

2015-09-01

[Biochem. Biophys. Res. Commun. 457(3) , 353-7, (2015)]

The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.

2014-04-01

[Hepatology 59(4) , 1283-92, (2014)]

Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney.

2014-04-01

[J. Am. Soc. Nephrol. 25(4) , 726-36, (2014)]

More Articles...